Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

Movement Disorders : Official Journal of the Movement Disorder Society
Jaime KulisevskyTrapecio Group Study

Abstract

A cross-sectional study of the profile of psychiatric symptoms and their relationships to medications, executive performance, and excessive daytime somnolence (EDS) was conducted on 1351 consecutive Parkinson's disease patients without dementia (PD-ND). Ratings were: neuropsychiatric inventory (NPI); hospital anxiety and depression scale (HADS); executive performance (semantic, phonemic, and alternating verbal fluencies); and the Epworth sleepiness scale (ESS). Eighty-seven percent of the subjects reported at least one psychiatric symptom. The most common were depression (70%), anxiety (69%), apathy (48%), and irritability (47%). Fifty percent of the patients had HADS-depression scores ranging from possible (8-10; 22%) to probable (>or=11; 28%) depression. Executive impairment was found in 41% and EDS in 26% of subjects. All considered variables were significantly more common with longer duration and more severe disease. Only depression appeared to be influenced by type of medication, being less prevalent among patients treated with DAs. Five NPI clusters were identified among patients scoring >or=1 on the NPI (87.3%): patients exhibiting predominantly apathy (12.7%), psychosis (3%), depression (13%), anxiety (15.6%), and "low-...Continue Reading

References

Jun 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·W R Gibb, A J Lees
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Oct 29, 1996·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T Shallice, P Burgess
Aug 26, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·M L LevyI Litvan
Nov 6, 1998·Statistical Methods in Medical Research·B S Everitt, S Landau
Sep 16, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·D AarslandJ L Cummings
Apr 28, 2000·The American Journal of Psychiatry·C G LyketsosJ C Breitner
Oct 14, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·K H KarlsenJ P Larsen
Dec 13, 2000·Neurology·B DuboisB Pillon
Feb 24, 2001·Psychological Medicine·A SchragN P Quinn
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J KulisevskyJ L Cummings
Feb 2, 2002·JAMA : the Journal of the American Medical Association·Douglas E HobsonJonathan Fleming
May 3, 2002·Journal of Neurology·Thomas FoltynieRoger A Barker
May 30, 2002·Neurology·M D GjerstadJ P Larsen
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·G C Pluck, R G Brown
Dec 7, 2002·Clinical Neuropharmacology·Johan MarinusJacobus J van Hilten
Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Francisco Grandas, Jaime Kulisevsky
Jul 10, 2003·Lancet Neurology·Murat Emre
Aug 26, 2003·Journal of Neural Transmission·K W LangeM Naumann
Nov 19, 2004·Fundamental & Clinical Pharmacology·Eric DaillyMichel Bourin
Feb 18, 2005·Brain : a Journal of Neurology·Philippe RemyDavid Brooks
Oct 26, 2005·Neurology·Dino MuslimovicBen Schmand
Jul 6, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·D AarslandJ L Cummings
Jul 13, 2006·Neurology·L Kirsch-DarrowD Bowers
Jul 20, 2006·The Journal of Clinical Psychiatry·Leora L BorekJoseph H Friedman
Nov 15, 2006·Neurology·James E GalvinJohn C Morris
Nov 23, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jaime KulisevskyCarmen García-Sánchez
Feb 10, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Kathy DujardinLuc Defebvre

❮ Previous
Next ❯

Citations

Apr 2, 2011·Acta Neuropathologica·Manuel F CasanovaKurt A Jellinger
Aug 26, 2009·Journal of Neurology·Kenn Freddy PedersenJan Petter Larsen
Jun 22, 2011·Journal of Neurology·Paulo BugalhoBernardo Neto
Jan 13, 2012·Journal of Neurology·Pablo Martinez-MartinKallol Ray Chaudhuri
Jun 23, 2011·Journal of Neural Transmission·Saül Martínez-Horta, Jaime Kulisevsky
May 15, 2012·Journal of Clinical Psychology in Medical Settings·Mary DelaneyPaul Geoffrey Overton
Aug 15, 2013·Current Neurology and Neuroscience Reports·Martijn L T M Müller, Nicolaas I Bohnen
May 18, 2010·Neurotoxicity Research·Thomas N Chase
Nov 20, 2012·CNS Drugs·David DevosRegis Bordet
Jan 6, 2012·The Neurologist·Oscar Bernal-PachecoHubert H Fernandez
Aug 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C BeckerC R Meier
Jan 13, 2012·Neuroepidemiology·Esther CuboUNKNOWN ANIMO Study Group
Mar 15, 2013·Dementia and Geriatric Cognitive Disorders·S LaatuR Marttila
Mar 1, 2011·Therapeutic Advances in Chronic Disease·Steven Wishart, Graeme J A Macphee
Oct 27, 2010·Parkinson's Disease·Mercè Martínez-CorralJaime Kulisevsky
Apr 20, 2014·Parkinson's Disease·Nicole C R McLaughlinJoseph H Friedman
Nov 8, 2014·TheScientificWorldJournal·Rocio García-RamosJorge Matías-Guíu
Jun 10, 2015·Expert Opinion on Drug Discovery·Cornelis J Van der Schyf
Oct 31, 2015·Journal of Neurology·Daniel Martinez-RamirezMichael S Okun
Jul 9, 2014·Neurological Research·Rômulo Lopes GamaSergio Tufik
Apr 7, 2016·Current Neurology and Neuroscience Reports·Jeffrey W Cooney, Mark Stacy
Jul 1, 2015·Journal of the Neurological Sciences·Hamad Alzahrani, Annalena Venneri
Jun 20, 2015·Journal of Movement Disorders·Yoon-Sang OhPhil Hyu Lee
Apr 16, 2015·Frontiers in Neurology·Maritza Sandoval-RincónOscar Arias-Carrión
Jul 10, 2010·Neuroscience and Biobehavioral Reviews·Karen L Eskow JaunarajsChristopher Bishop
Sep 10, 2013·Clinical Therapeutics·David DevosRegis Bordet
Oct 20, 2009·European Journal of Pharmacology·María José Fernández-SerranoAntonio Verdejo-García
Jul 22, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Nadeeka N N W DissanayakaGerard J Byrne
Jan 12, 2017·Evidence-based Mental Health·Ivan Koychev, David Okai
Mar 27, 2015·Journal of Geriatric Psychiatry and Neurology·Jeffrey CummingsPhilippe H Robert
Apr 17, 2013·Journal of Geriatric Psychiatry and Neurology·Roseanne D DobkinMatthew Menza
Sep 14, 2016·OTJR : Occupation, Participation and Health·Sara G LutzAndrew M Johnson
Dec 8, 2010·Neuro-degenerative Diseases·Ramona Lucas-CarrascoJuana Gómez-Benito
Nov 22, 2017·Neurodegenerative Disease Management·Ruth B SchneiderIrene H Richard
Dec 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneDaniel Weintraub
Aug 7, 2010·International Journal of Geriatric Psychiatry·E MulinP H Robert
Jun 11, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Stephanie M van RoodenJohan Marinus
Oct 17, 2017·Journal of the International Neuropsychological Society : JINS·Sarah M SzymkowiczDawn Bowers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.